Last $6.89 USD
Change Today +0.16 / 2.38%
Volume 225.5K
CNAT On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven J. Mento Ph.D.

Co-Founder, Chief Executive Officer, President and Director, Conatus Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 120 board members in 3 different organizations across 4 different industries.

See Board Relationships
62$647,633
As of Fiscal Year 2013

Background*

Dr. Steven J. Mento, Ph.D., Co-founded Conatus Pharmaceuticals Inc. in 2005 and has been its Chief Executive Officer and President since July 2005. Dr. Mento has over twenty years of combined experience in the biotechnology and pharmaceutical industry, ten of which served as President and Chief Executive Officer. Dr Steven served as the President and Chief Executive Officer of IDUN Pharmaceuticals, Inc. from August 1997 to 2005. Dr. Mento joined Idun in 1997. From 1982 ...

Read Full Background

Corporate Headquarters*

4365 Executive Drive
San Diego, California 92121

United States

Phone: 858-558-8130
Fax: --

Board Members Memberships*

Director
1997-N/A
Former Chief Executive Officer, President and Director
2005-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
2005-Present
Co-Founder, Chief Executive Officer, President and Director
2006-N/A
Former Chairman of the Board

Education*

MS
Rutgers, The State University of New Jersey
PhD
Rutgers, The State University of New Jersey
BA
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$419,473
Total Annual Compensation$419,473

Stock Options*

All Other Compensation$18,424
Exercisable Options248,484
Exercisable Options Value$1,347,632
Total Value of Options$1,347,631
Total Number of Options248,484

Total Compensation*

Total Annual Cash Compensation$647,633
Total Short Term Compensation$419,473
Other Long Term Compensation$18,424
Total Calculated Compensation$647,633
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNAT:US $6.89 USD +0.16

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONATUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.